← Back to Search

Negative Affect Task for Binge Eating Disorder

N/A
Waitlist Available
Led By Guido KW Frank, MD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Binge Eating Disorder: Age 18-55 years old, Edinburgh Handedness Inventory Revised (EHI-R) LQ* score > +200, DSM 5 diagnosis of Binge Eating Disorder with specific criteria
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying how well brain imaging works in people with binge eating disorder or bulimia nervosa.

Who is the study for?
Adults aged 18-55 with obesity (BMI > 30 kg/m2) and diagnosed with Bulimia Nervosa or Binge Eating Disorder, experiencing marked distress from binge eating. Participants should have a stable weight and food intake for the past month, no major medical illnesses, no history of substance abuse or certain psychiatric disorders, not pregnant or breastfeeding, and without metal implants.
What is being tested?
The trial is studying how negative emotions affect people with bulimia nervosa and binge eating disorder. It aims to link these feelings to brain function related to reward learning, food value computation, cognitive control circuits, and whether this can predict future eating behavior.
What are the potential side effects?
Since this study focuses on behavioral tasks rather than medication or invasive procedures, significant side effects are not expected. However, participants may experience emotional discomfort when discussing their eating habits or during assessments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18-55 years old with Binge Eating Disorder and right-handed as per the EHI-R.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Brain Activation and Food Intake/negative Affect Relationships
Food Choice Brain Response to Negative Affect fMRI Task
Taste Reward Brain Response to Negative Affect fMRI Task

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: BehavioralExperimental Treatment1 Intervention
Negative Affect Task

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,180 Previous Clinical Trials
1,574,636 Total Patients Enrolled
Sanford ResearchOTHER
5 Previous Clinical Trials
789 Total Patients Enrolled
University of Colorado, DenverOTHER
1,805 Previous Clinical Trials
2,821,936 Total Patients Enrolled

Media Library

Negative Affect Task Clinical Trial Eligibility Overview. Trial Name: NCT03393039 — N/A
Binge Eating Disorder Research Study Groups: Behavioral
Binge Eating Disorder Clinical Trial 2023: Negative Affect Task Highlights & Side Effects. Trial Name: NCT03393039 — N/A
Negative Affect Task 2023 Treatment Timeline for Medical Study. Trial Name: NCT03393039 — N/A
~5 spots leftby Dec 2024